MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
28.04
-1.20
-4.10%
Opening 14:44 04/20 EDT
OPEN
29.23
PREV CLOSE
29.24
HIGH
29.25
LOW
27.62
VOLUME
69.83K
TURNOVER
--
52 WEEK HIGH
39.71
52 WEEK LOW
9.37
MARKET CAP
444.79M
P/E (TTM)
-51.3459
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ASMB last week (0413-0417)?
Weekly Report · 12h ago
Weekly Report: what happened at ASMB last week (0406-0410)?
Weekly Report · 04/13 09:23
Assembly Bio highlights positive Phase 1b HSV data for ABI-5366 at ESCMID 2026
Reuters · 04/09 12:08
Assembly Biosciences Presents Phase 1b Data For ABI-5366 And ABI-1179 At ESCMID Global
Benzinga · 04/09 12:07
Assembly Biosciences (ASMB) Gets a Buy from Guggenheim
TipRanks · 04/06 16:05
Assembly Biosciences Is Maintained at Buy by Guggenheim
Dow Jones · 04/06 12:07
Guggenheim Maintains Buy on Assembly Biosciences, Raises Price Target to $43
Benzinga · 04/06 11:56
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
TipRanks · 04/06 10:45
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.